The TMPRSS2-ERG fusion is a genetic rearrangement commonly found in prostate cancer. It results from the fusion of the TMPRSS2 gene, which is androgen-regulated, with the ERG gene, a member of the ETS transcription factor family. This fusion leads to the overexpression of the ERG oncogene, promoting cancer development and progression.
